24 Hrs
Source:
المشهد العربي
New Treatment for Pancreas
The U.S. Food and Drug Administration (FDA) has approved a new medication for the treatment of advanced pancreatic cancer, providing a more effective therapeutic option for patients suffering from this highly lethal form of cancer. The drug is called "Rasonque" and is manufactured by Revolution Medicines. Its goal is to target mutations in the "RAS" genes, particularly the "KRAS" mutation, which plays a key role in the growth of pancreatic tumors. This development marks an important step in improving treatment for the disease, which affects many people worldwide.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)